Developing small molecule therapeutics for cancer.
Total raised: $101M
Investors 3
| Date | Name | Website |
| - | US Venture... | usvp.com |
| - | 5AM Ventur... | 5amventure... |
| - | OrbiMed | orbimed.co... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 06.08.2019 | - | $12M | - |
| 08.08.2016 | Series B | $37M | - |
| 09.04.2013 | Series A | $10M | - |
| 11.10.2011 | Series A | $42M | - |
Mentions in press and media 7
| Date | Title | Description |
| 07.08.2019 | Daily funding roundup - August 7th, 2019 | EnjoyHQ raised $2M; Eager Alpha closed $2.4M; LUCA Biologics landed $2.8M; Crosschq secured $4.1M EnjoyHQ: EnjoyHQ is the easiest way to search, organize and share all your customer feedback and user research in one place. EnjoyHQ has raise... |
| 06.08.2019 | Cleave Therapeutics Appoints Amy Burroughs Chief Executive Officer and Completes $12 Million Equity Financing | - |
| 06.08.2019 | Cleave Therapeutics Appoints Amy Burroughs Chief Executive Officer and Completes $12 Million Equity Financing | - |
| 08.08.2016 | CLEAVE BIOSCIENCES RAISES $37 MILLION SERIES B FINANCING | - |
| 09.04.2013 | CLEAVE BIOSCIENCES ADDS NEW INVESTOR AND $10 MILLION TO SERIES A FINANCING | - |
| 11.10.2011 | Cleave Biosciences Raises $42M in Series A Financing | Cleave Biosciences, a Burlingame, California-based newly established biopharmaceutical company discovering and developing novel therapies for cancer, has raised $42m in Series A financing. Investors include U.S. Venture Partners, 5AM Ventur... |
| 11.10.2011 | CLEAVE BIOSCIENCES RAISES $42 MILLION IN SERIES A FINANCING FOR NOVEL CANCER THERAPIES | - |